Alex Dusek | Global Brand Strategy Leader
Bayer

Alex Dusek, Global Brand Strategy Leader, Bayer

Share this
Appearances at this years' conference:

Day One Wednesday 21 March 2012


@ 12.10
Case study: Peri-approval strategy trials during evolving combination therapy standards of care: Learnings from HIV and PAH

• Providing evidence to support product claims and develop data in expanded populations of patients
• Clinical program design to evaluate real-world outcomes
• Addressing the challenges of US and EU regulatory requirements

  • › Alex Dusek, Global Brand Strategy Leader, Bayer

sponsor Late Phase Drug Development World Americas 2012 ›

Sponsors
Session Facilitators
PRA International at Late Phase Drug Development World Americas 2012
Session presentation sponsor
Medidata Solutions Inc at Late Phase Drug Development World Americas 2012
Session presentation sponsor
OptumInsight at Late Phase Drug Development World Americas 2012
Session presentation sponsor
Oracle Corporation UK Limited at Late Phase Drug Development World Americas 2012
Session presentation sponsor
CRF Health at Late Phase Drug Development World Americas 2012
Session presentation sponsor
PharmaNet/i3 at Late Phase Drug Development World Americas 2012
Session presentation sponsor
United BioSource Corporation at Late Phase Drug Development World Americas 2012

sponsors list ›